In classical Mendelian inheritance, each parent donates a set of chromosomes to its offspring so that maternally and paternally encoded information is expressed equally. The phenomena of X-chromosome inactivation (XCI) and autosomal imprinting in mammals violate this dogma of genetic equality. In XCI, one of the two female X chromosomes is silenced to equalize X-linked gene dosage between XX and XY individuals. In genomic imprinting, parental marks determine which of the embryo's two autosomal alleles will be expressed. Although XCI and imprinting appear distinct, molecular evidence now shows that they share a surprising number of features. Among them are cis-acting control centers, long-distance regulation and differential DNA methylation. Perhaps one of the most intriguing similarities between XCI and imprinting has been their association with noncoding and antisense RNAs. Very recent data also suggest the common involvement of histone modifications and chromatin-associated factors such as CTCF. Collectively, the evidence suggests that XCI and genomic imprinting may have a common origin. Here, I hypothesize that the need for X-linked dosage compensation was a major driving force in the evolution of genomic imprinting in mammals. I propose that imprinting was first fixed on the X chromosome for XCI and subsequently acquired by autosomes. 
nuclear transfer experiments in mice showed that maternal and paternal haplo-genomes are not equivalent, and suggested that the mother and father stamp complementary genetic imprints on their respective chromosomes [28, 29] . As shown by experiments of Bruce Cattanach's group [30] and subsequently by the identification of numerous imprinted domains (http://www.mgu.har.mrc.ac.uk/imprinting), a significant fraction of the mouse genome is now known to carry parental imprints which restrict the expression of one allele. To date, more than 50 genes exhibiting parent-of-origin effects have been described, but genetic studies in mice suggest the existence of many more genes, as well as chromosomal regions, with parent-of-origin effects (Figure 1 ). Among the bestknown imprinted genes in mammals are those in the H19/Igf2 locus, the Prader-Willi and Angelman Syndrome complex (PWS/AS), the Beckwith Wiedemann Syndrome (BWS) locus, the callipyge locus and the Igf2r/Air locus (see below).
Although imprinted genes serve diverse functions and are responsible for a wide range of human and animal diseases, molecular analyses have highlighted a number of recurrent themes. These include the propensity of imprinted genes to cluster, the occurrence of differentially methylated regions, and the ubiquity of noncoding and antisense RNAs. Many of these intriguing features are also found in the Xic. Together, these remarkable similarities suggest that genomic imprinting and XCI may share more than mere co-classification as epigenetic phenomena. At the end of this review, I propose the contrary idea that the XCI may have been a major impetus for the evolution of an imprinting mechanism in mammals.
Molecular Parallels between Imprinting and XCI Clustering of Genes Subject to Imprinting and XCI
Since the discovery of the first imprinted genes, over 50 have been described in mouse and humans (http://www.mgu.har.mrc.ac.uk/imprinting). One intriguing characteristic of nearly all imprinted genes is that they do not occur isolated in the genome, but rather in clusters dispersed over large distances ( This type of co-clustering suggests that there may be a purpose for the grouping of imprinted genes. Otherwise, one might expect to see clusters in which all alleles of that cluster are expressed only when transmitted from one parent. Imprinting takes place on 13 mouse chromosomes ( Figure 1 ) [30] , indicating that imprinting has become well fixed in eutherian mammals. In some chromosomes, the imprinted clusters are quite large. A most impressive example occurs on mouse chromosome 7, over which at least four large and independently regulated clusters can be found. The H19/Igf2 cluster spans more than 100 kilobases of sequence [32, 33] . Its neighboring Beckwith-Wiedemann Syndrome locus spans several hundred kilobases and includes Kvlqt1 (which encodes a voltage-gated K channel associated with long QT syndrome), its antisense counterpart and p57 kip2 [34] . Further up the chromosome is the Peg3 imprinted cluster and the syntenic region of the human PWS/AS locus [35] . In humans, this locus spans chromosome 15q11-13, a region of 4 megabases including more than a dozen imprinted genes. To date, ~20 independently regulated imprinted domains have been identified in the mouse genome (http:// www.mgu.har.mrc.ac.uk/imprinting/all_impmaps.html) and there are probably a similar number of domains in the human genome (http://www.genes.uchicago.edu /upd). Between mouse and human, there appears to be a nearly perfect conservation of imprinting. One notable exception is Igf2r, which is imprinted in mice but not in humans [9, 36] .
The tendency towards gene clustering is also apparent in XCI. While we tend to think of XCI as a pan-chromosomal phenomenon, not all X-linked genes are subject to inactivation. On the human X, genes subject to silencing and those that escape XCI are blocked into large domains. A first generation Xinactivation profile estimates that ~10% of the human X escapes silencing [37, 38] . An overwhelming majority of these escapees resides on the short arm (Xp), accounting for ~35% of the genes on the short arm and including the pseudoautosomal region as well as at least two other large clusters. This clustering suggests that regional control elements determine the transcriptional competence of X-linked genes. Thus, control of both imprinted and X-linked genes involves the organization of chromatin into higher-order chromosome structures. How are these domains determined, and what forces partition the transcriptional status between domains? Is there a pattern to what initially appeared to be lack of organization among the clustered loci? As discussed below, research over the past 10 years points increasingly to some semblance of pattern among the disparate loci.
A Plethora of Noncoding and Antisense RNAs
One of the oddest features of imprinted domains and the Xic is the abundance of noncoding transcripts (Figure 2) . It has been estimated that ~27% of known human and mouse imprinted genes are noncoding in nature [9] , and many of these have no obvious function. One of the first discovered is H19 [33] -the reciprocally imprinted partner of the insulin-like growth factor 2 locus Igf2 [32] -which is apparently dispensable in mice despite its well-conserved nature. In addition to its sense transcript, the Igf2 locus can produce a noncoding antisense transcript (Igf2as), the function of which is also unclear [39] . The critical region associated with Angelman Syndrome, the E6-AP ubiquitinprotein ligase locus Ube3a, is paired with a very long antisense RNA [40] that apparently initiates far downstream in the Prader-Willi imprinting center, and is part of a 'multicistronic' RNA precursor that gives rise to numerous small nucleolar (sno)RNAs [41] . Within the Beckwith-Wiedemann Syndrome locus, the potassium voltage-gated channel gene Kvltq1 has a noncoding antisense RNA partner, Kcqlot1 [42] .
One of the best studied autosomally imprinted antisense genes is Air, which encodes the antisense transcript of the mouse insulin-like growth factor receptor 2 locus Igf2r [43] . Air initiates within an intronic CpG island in Igf2r and is likely transcribed for more than 108 kilobases off the opposite DNA strand [44] (Figure 2 ). Paternal expression of Air RNA is necessary for cis-silencing of Igf2r and also of two non-overlapping genes, Slcc22a2 and Slcc22a3, as shown by the reexpression of the paternal alleles when the Air CpG island is deleted [43, 45] . Recent work suggests that this antisense repressive mechanism may depend on the RNA, as truncation of the paternal Air transcript leads to upregulation of all three maternally expressed Igf2r, Slcc22a2 and Slcc22a3 alleles [46] . Mutations in the maternal Air allele have no effect at all, consistent with the normal silence of this allele. Because truncation of Air RNA also affects the non-overlapping genes, Slcc22a2 and Slcc22a3, it is proposed that Air RNA may resemble Xist RNA in that it may 'paint' the entire imprinted domain on the paternal chromosome (in cis). It is also possible, however, that the transcription of Air may induce chromatin changes in Igf2r which then spread to Slc22a2 and Slc22a3.
Considerable effort has been devoted to studying non-coding genes that lie in and around the Xic. At least four have been described in mice, including Xist The action of Xist is antagonized by Tsix. Tsix knockout and knock-in analyses showed that the antisense gene blocks the spread of Xist RNA along the X. In heterozygous (-/+) female embryonic stem (ES) cells, the choice of which X is inactivated is completely skewed towards the targeted chromosome, so that Xist is upregulated only on the chromosome lacking antisense expression [25, 54, 55] . Conversely, when the constitutive EF1α α promoter or a tetracyclineinducible promoter is used to drive high-level and persistent antisense expression from one female X, XCI can no longer take place on that chromosome, demonstrating that Tsix transcription is sufficient to inhibit the action of Xist [26, 27] .
Throughout the process of XCI, the sense and antisense transcripts have a dynamic pattern of expression that belies their regulatory relationship [24] . In undifferentiated female ES cells, Tsix and low-levels of Xist RNA are expressed on both X chromosomes. This co-expression suppresses the upregulation of Xist. During differentiation of female ES cells, Tsix RNA expression is lost on the presumptive future Xi chromosome. Intriguingly, Xist RNA is upregulated on the very X chromosome that has lost Tsix expression, resulting in the formation of a 'Xist RNA cloud' coating the entire Xi, which might recruit silencing proteins to that X. On the future Xa, the persistence of Tsix prevents formation of the Xist RNA cloud. Taken together, these data demonstrate that the two opposing, noncoding RNAs function in the determination of X chromosome choice and whether silencing will take place on each X.
Several possible mechanisms of Tsix action have been discussed [6] . One school of thought suggests that antisense transcription is merely incidental and that Tsix really functions through a region of specialized chromatin that acts on Xist at long range. A second contends that Tsix transcription in the antisense direction provides a repressive force against Xist. Yet another proposes that Tsix RNA is functional and titrates out the sense RNA by either enhancing its degradation or blocking Xist's silencing domains. While these models remain to be tested, Tsix overexpression studies show that its transcription can block Xist-induced silencing [26, 27] .
A more recent analysis of Tsix RNA structure and quantity has further implications for how Tsix works [56] . Prior to the onset of XCI, Tsix RNA is present at a 10-100-fold molar excess over Xist RNA, consistent with a model in which Tsix RNA titrates Xist RNA. Only 30-60% of Tsix RNA is spliced at known exon-intron boundaries -a strange observation in itself, given Current Biology R245 The functional importance of DNA methylation has also been demonstrated by studies of mouse knockout mutants defective in various DNA methyltransferases, which showed that differential methylation is required to set imprints in the germ line [57] . Loss of Dnmt1 results in mid-gestational lethality, with embryos exhibiting dysregulation in imprinted gene expression [59, 60] . Dnmt1 is believed to encode the major 'maintenance' methyltransferase, so this result implies that DNA methylation is required to keep the maternal and paternal epigenotypes at imprinted loci.
Curiously, Dnmt1 has an oocyte-specific isoform (Dnmt1 o ), the maternally-loaded protein product of which is required during the fourth zygotic S phase to maintain the maternal pattern of DNA methylation [61] . A sperm-specific promoter is also found in Dnmt1 [57] , and this may direct production of the reciprocal activity in the paternal germline. A role in imprinting has also been described for Dnmt 3L, a noncatalytic protein in the DNA methyltransferase family with sequence similarity to the 'de novo' methyltransferases Dnmt3a and Dnmt3b. Dnmt3L -/-embryos also lack maternal-specific methylation and die shortly after implantation with embryonic and extraembryonic abnormalities [62] . The methylation defect is specific to imprinted regions and does not affect global DNA methylation.
Yet another maternal-effect mutation was recently identified as the cause of a pervasive human imprinting disorder, in which maternal-specific methylation patterns at multiple discontiguous loci are converted to the paternal epigenetic pattern [63] . This results in conceptuses with two paternal epigenotypes that resemble the classical androgenetic hydatidiform mole. While the responsible gene has not yet been pinpointed, preliminary data argue against a mutation in DNMT3L. The sum of these intriguing findings in mice and humans clearly demonstrates that parental imprints are set by the action of germline-specific DNA methyltransferases on CpG-rich regions in imprinted domains.
The Xic also contains CpG islands that display differential methylation. In mice, the 5′ ′ end of Xist harbors a CpG island which is hypermethylated in oocytes and undermethylated in sperm [64, 65] . This pattern correlates with preferential Xist expression from the paternal allele in preimplantation embryos and in the imprinted extraembryonic tissues of mice, suggesting that differential methylation in the Xist promoter may be a primary signal governing imprinted XCI [66] . Consistent with a role for DNA methylation, male somatic cells lacking Dnmt1 show derepression of Xist and, in some cells, inappropriate formation of an Xist RNA cloud on their only X chromosome [67, 68] . The extraembryonic tissues, however, appear to be relatively immune to this deficiency of Dnmt1, as XCI still properly takes place on the paternal X [69] . Upstream of Xist lies the Jpx/Enox noncoding gene with a CpG island that apparently remains unmethylated in somatic cells (no data are available yet on the status in sperm and oocytes) [47, 48] . The functional significance of this noncoding gene is currently not certain, especially in light of the finding that at least part of the gene may be an expressed pseudogene [48] .
In the region downstream of Xist lie two other CpG islands. One is ~15 kilobases upstream of Tsix but does not appear to play a significant role in XCI, because its deletion resulted in normal mice with no anomalies in imprinted or random XCI [55] . A very prominent island occurs at the 5′ ′ end of Tsix, including both its promoter and 2 kilobases of the transcribed region that harbors a repeat element known as DXPas34 [70] . Deletion of this CpG island results in completely skewed XCI in somatic cells and a loss of imprinted XCI in the extraembryonic tissue, indicating that this region contains a sequence responsible for the designation of X chromosomes as Xa or Xi [54, 55] . In pre-implantation embryos, bisulfite sequencing of the 1.1 kilobase DXPas34 repeat has not found the CpG dinucleotides to be differentially methylated, although the status of remaining CpGs in the large island has yet to be described [71] .
The occurrence of multiple CTCF binding sites in DXPas34 and surrounding unique sequence has led to the thinking that they act either directly as transcriptional stimulators or indirectly as chromatin insulators that block Xist from accessing an unidentified enhancer upstream of Tsix [72] . CTCF protein also binds to the differentially methylated region of H19/Igf2 and has been proposed to regulate imprinting by acting as a chromatin insulator against an enhancer competed for by the two reciprocally imprinted genes (see below) [73] [74] [75] . In light of this similarity, the possibility that the Tsix CpG island may be differentially methylated merits examination beyond DXPas34. Without differential methylation, the CpG island may regulate Tsix gene activity through other chromatin-associated changes. In tissues that undergo random XCI, this same ICR element plays a role in X chromosome choice [25] . Deleting this element on one female X results in near exclusive inactivation of the X chromosome carrying the Tsix deletion, indicating that it is required to keep the X active. Deleting the second copy of this element further alters the choice decision [78] : an excess of female embryos is lost around the implantation stage, but surviving female mice show a paradoxical 'reversion' to a random pattern of XCI. This reversion does not reflect a true return to the wild-type state, however, as it comes at the cost of losing approximately half of the female embryos.
Cis-Acting Switches
Combined, these genetic studies implicate the CpG island of Tsix as an epigenetic switch that determines whether the linked Xist gene will be upregulated. The dual role of this Tsix element in controlling imprinting and random choice supports the idea that imprinting and random XCI are evolutionarily linked. Indeed, our laboratory has postulated that random XCI evolved from imprinted XCI by relaxing the stringency of imprinting and by shifting the control of X inactivation choice from parent to zygote [7, 54] . Current Biology alone exhibit the 'round buttocks' phenotype, but those inheriting the mutation from both parents are wild type [79] . Polar overdominance at callipyge has been hypothesized to involve a complex set of transallelic interactions among genes of the imprinted Dlk1/Gtl2 locus [80] .
Trans-Allelic Interactions
Similarly, the overdominant phenotype at Tsix has also been proposed to result from the loss of transinteractions. During XCI, the two X chromosomes in females must coordinate the decision to be inactivated or remain active -a decision which must involve some level of chromosome-to-chromosome cross-talk. From observations on Tsix -/-mice, our laboratory has hypothesized that the trans-interaction may be mediated by Tsix. In the absence of both Tsix alleles, chromosome choice would be made 'chaotically' and surviving female mice would be those in whom a majority of cells selected distinct Xs as the Xa and Xi.
Interestingly, trans-allelic cross-talk has also been proposed for the Prader-Willi/Angelman Syndrome locus. Cytologic measurements of the human 15p11-13 chromosome region show that the two alleles of the imprinted domain come together during S phase, suggesting that there may be a specific window during the cell-cycle when the PWS/AS region might 'pair'. It is suggested that homologous pairing at critical periods may be necessary to establish or maintain the imprinted pattern of expression [81] . Further, possibility of allelic cross-talk is also evident at H19/Igf2, where transallelic methylation is seen upon mutation of the CTCF binding sites in the ICR [82] . The possibility of homologous trans-interactions would help explain many aspects of how imprinted regions and the Xics of female cells are coordinately regulated. It is an idea that would further unite XCI and autosomal imprinting and that certainly merits greater investigative effort in coming years.
CTCF
With the identification of the first cis-acting switches, many labs have turned their attention to trans-factors that bind these elements. One recently identified factor is the CCCTC-binding factor (CTCF), an 11-zinc finger transcription factor that has been described variously as an activator, repressor and chromatin insulator element [83] (Figure 2) . Through differential zinc finger usage, CTCF can bind to a diverse repertoire of DNA sequences. One recent breakthrough in the imprinting field came with the recognition that CTCF works as a transcriptional switch between H19 and Igf2 by acting as a regulatable chromatin boundary (Figure 3) [73-75] . It was previously shown that, when the ICR is methylated (paternal chromosome) Igf2 is expressed, and when it is unmethylated (maternal chromosome) H19 is expressed. In vitro experiments identified four methylation-sensitive CTCF binding sites within this ICR which modulate the activity of the ICR. Functional assays in vivo showed that these CTCF sites have enhancer-blocking activity.
It is therefore proposed that CTCF and the ICR together create a chromatin insulator that serves as an epigenetic switch to regulate the mutually exclusive access of H19 and Igf2 to a set of shared enhancers. When CTCF binds to the unmethylated ICR, access of Igf2 to distal enhancers is blocked and H19 is activated by default. Conversely, when methylation prevents CTCF binding, H19 is bypassed and Igf2 is activated by the enhancers. Creation of mice with point mutations in the CTCF binding sites within the Igf2/H19 ICR leads to loss of enhancer blocking and Igf2 activation on the mutant maternal chromosome [82, 84] . Interestingly, maternal H19 expression is also reduced, suggesting that CTCF may also be a direct transcriptional activator for H19 in addition to being a chromatin insulator for Igf2.
In vivo experiments have also demonstrated that mutating CTCF binding sites within the Igf2/H19 ICR disrupts maintenance, but not initiation of differential methylation [84] . This suggests that CTCF does not set up differential methylation of the ICR in the germ line, and that something else must carry out this important role. One candidate factor is the germ cellspecific paralog of CTCF, named 'BORIS' (Brother of the Regulator of Imprinted Sites) [85] . In contrast to the ubiquitous expression of CTCF, expression of BORIS is restricted to primary spermatocytes during the time of genome remethylation, a time when resetting of genomic imprints is believed to occur. Intriguingly, BORIS has a similar DNA-binding domain as CTCF, suggesting that ICRs in male germ cells may use BORIS to establish differential methylation or to 'read' the differentially methylated codes.
The discovery of potential CTCF sites at other imprinting centers may speak for generalized conservation of CTCF-mediated imprint regulation. CTCF motifs have also been identified within a differentially methylated region of the Dlk1/Gtl2 locus [86] (Figures  2,3) . This locus bears striking resemblance to the wellcharacterized H19/Igf2 locus. Dlk1 and Igf2 are both protein-coding genes and are paternally expressed, while Gtl2 and H19 make noncoding RNAs, which are both maternally expressed [87] . Furthermore, like H19 and Igf2, Dlk1 and Gtl2 are positioned 80 kilobases apart in the same relative orientation, and a differentially methylated region is positioned between the reciprocally imprinted genes [86, 87] . Comparative genomic analysis pinpointed putative CTCF-binding sites in Gtl2, within one of its introns [86] , thus offering the possibility that CTCF may also function here to control parent-of-origin-specific expression.
Computational analysis has also led to the identification of CTCF-binding sites within the imprinting/choice center for X inactivation [72] (Figures 2,3) . Autosomally imprinted loci have also been shown to exhibit differential histone tail modifications between alleles. The Prader-Willi/Angelman Syndrome locus contains a bipartite imprinting center which regulates parent-of-origin-specific expression pattern genes along the 2-4 megabase region in a cis-limited fashion [35] . It is believed that the AS-SRO -the shortest region of overlap for the AS imprinting center -fires only on the maternal chromosome, thereby enabling maternal-specific expression of UBE3A and ATP10C. On the paternal chromosome, the PWS-SRO fires and allows for expression of numerous paternal-specific transcripts in cis. Recent work has shown that the AS-SRO is hypermethylated on H3 K4 and hyperacetylated H4 only on the active maternal allele, and that it likely represses the activity of the PWS-SRO in cis, possibly setting up the observed differential sensitivity to DNaseI at the PWS-SRO [95] . Allele-specific differences in H3 methylation and acetylation also occur on Igf2r and U2af1-rs1 in mice [96] . Therefore, differential histone modifications may be yet another unifying feature of Xlinked and autosomally imprinted loci.
Differential chromatin states on epigenetically regulated loci also involve recruitment of non-histone proteins. Several intriguing non-histone proteins have been associated with the Xi. Polycomb group proteins have emerged as repressors of X-linked gene expression and downstream effectors of Xist RNA-mediated silencing. In mice, the Eed protein is required to maintain imprinted silencing of the paternal X in extraembryonic tissues. Embryos lacking Eed die after implantation, partly because of reactivation of the previously silent paternal X [97] . By immunofluorescence, Eed and another Polycomb group protein, Ezh2, have been shown to be enriched on the Xi in trophoblast stem cells [53] . The similar 'painting' pattern of Eed, Ezh2 and Xist RNA has led to speculation that the two Polycomb group proteins may be one of the immediate downstream targets of Xist RNA.
Interestingly, Ezh2 contains a SET domain and has been shown to be an H3-K27, and likely also an H3-K9, methyltransferase in Drosophila and mammals [98] [99] [100] [101] . Given the H3-K9 hypermethylation on the Xi, it is tempting to speculate that Ezh2 may be the enzyme responsible for this epigenetic mark, especially given that genetic analysis has shown that the H3-K9 methyltransferases Suv39-h1 and h2, responsible for methylation at other heterochromatic loci, are not responsible for XCI [92] . Polycomb group proteins may also regulate imprinting on autosomes. Compound Eed heterozygotes carrying one null and one hypomorphic allele show ectopic Mash2 expression, suggesting that Eed may play some role in either the establishment or maintenance of autosomally imprinted genes [97] . So Polycomb proteins may have repressive roles in both XCI and autosomal imprinting. Metatherians Silencing E u t h e r i a n s Two other attractive models postulate that imprinting first arose to deal with maternal-fetal tolerance [9] or to foster placental development [107] . Indeed, among vertebrates, imprinting is so far only known to occur in marsupial and eutherian mammals, both of whose fetuses spend at least some time in intra-uterine gestation. Theoretically, by silencing paternally expressed histocompatibility genes, the fetus would minimize detection by the maternal immune system. However, paternally silenced histocompatibility genes have not been identified. Still others argue that imprinting arose to prevent parthenogenesis by necessitating contributions from both parents [28, 29, 31] . Another hypothesis posits that imprinting is merely a manifestation of a capricious epigenetic arms race and is not necessary for development or evolution at all [108] . Finally, the idea that imprinting might have evolved as one way to effect sex-specific X-linked gene expression has also been advanced [109] . Diverse as they are, these hypotheses are not mutually exclusive and all may have played some role in the evolution of imprinting.
It is interesting to note that autosomal imprinting is often treated as a mechanism distinct from XCI (summaries at http://www.mgu.har.mrc.ac.uk/imprinting; http://www.genes.uchicago.edu/upd). However, several investigators long noted the striking similarities between these two epigenetic phenomena [ , and occurs to a variable extent along that X in different tissues [114] .
I argue that, as only female offspring can inherit the paternal X, adopting an imprinted silencing mechanism for the paternal X would have solved the problem of dosage compensation without the need to simultaneously evolve an X chromosome counting mechanism ( Figure 4A,B) . Although very little is presently known about how counting takes place, counting is believed to involve a complex mechanism of measuring the X-to-autosome ratio, so its evolution would have in itself been a very demanding process. By proposing that dosage compensation drove the evolution of imprinting, I do not mean that noncoding RNAs, antisense transcripts, CTCF and the other discussed elements originated at the Xic. This is almost certainly not the case -I suspect that these elements were already established in mammalian ancestors and synapsids for purposes other than XCI or imprinting. What I postulate is that the Xic may have been one of the first to integrate these disparate elements and that, in doing so, established the earliest mechanism of genomic imprinting in mammals. This hypothesis benefits from the fact that dosage compensation was a very real evolutionary force during the early course of mammalian radiation.
Once imprinting was fixed on the X, I suggest that the molecular machinery was co-opted by autosomes to deal with various biological challenges on a more localized scale ( Figure 4A ). These challenges may include any of those previously proposed by others, such as dosage regulation in maternal-paternal conflicts [106] , fixation of sexual reproduction (antiparthenogenesis theory [28, 29] ), establishment of maternal-fetal tolerance [9] and acquisition of further ammunition for the epigenetics arms race [108] . The acquisition of imprinting by autosomes may initially involve a transposition or duplication event that imports elements at the Xic -such as non-coding RNAs, CTCF and cis-acting switches -for such novel purposes. The model predicts that transposition or duplication occurred repeatedly over the course of evolution, either from the original X-linked locus or subsequently from autosomal loci that have them-selves already acquired imprinting. One likely case of autosomal duplication involves H19/Igf2 (mouse chromosome 7) and Dlk1/Gtl2 (mouse chromosome 12), for which the strikingly similar genetic organization implicates a very recent shared origin (Figure 2 ). It is envisioned that imprinting elements would evolve continually at each locus to adapt to its particular needs. Such a model would explain why XCI and autosomal imprinting share many molecular features at the same time that they are unique in molecular details.
On the X chromosome, a relaxation of imprinting to a stochastic mechanism appears to have occurred subsequently during the metatherian-to-eutherian transition ( Figure 4A ). This step towards random choice is teleologically advantageous to the species and evolutionarily beneficial for the female, as it not only provides greater phenotypic variation for the species but also lessens the impact of deleterious maternal X-linked mutations on the female offspring. This progression from imprinted to random XCI must have been accompanied by the evolution of an X chromosome counting mechanism that enables the developing zygote to determine whether it has the need for dosage compensation (XX versus XY). Theoretically, by evolving an imprinted form of dosage compensation first, early mammals postponed the problem of X chromosome counting for its evolutionary descendants.
Admittedly, the available molecular and evolutionary evidence cannot distinguish among the evolutionary model proposed here and those proposed previously by others. Notably, autosomal imprinting appears to have evolved around the same time as and not before XCI -both are already present in metatherians [104, 105, 112, 113] . But because neither has so far been described in monotremes, the question of which came first -XCI or autosomal imprintingcannot be answered at this time. For the reasons stated, the model proposed here has the advantage of invoking a very real and strong evolutionary pressure as the driving force for establishment of an imprinting mechanism. Ultimately, only by looking back in time can we piece together answers to this compelling question. Fortunately, several species of monotremes and marsupials still exist today. Detailed investigation of the character of dosage compensation and autosomal imprinting in extant mammalian ancestors will be essential for solving the problem of why and how gametic imprinting evolved in mammals.
